{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:36:09Z","timestamp":1789673769235,"version":"4.0.1"},"reference-count":49,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T00:00:00Z","timestamp":1624492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), discovered in 2019, is responsible for the global coronavirus disease 19 (COVID-19) pandemic. The main protein that interacts with the host cell receptor is the Spike-1 (S1) subunit of the coronavirus. This subunit binds with receptors present on the host cell membrane. It has been identified from several studies that neuropilin-1 (NRP-1) is one of the co-receptors for SARS-CoV-2 entry. Therefore, in this review, we focus on the significance of NRP-1 in SARS-CoV-2 infection. MEDLINE\/PubMed database was used for a search of available literature. In the current review, we report that NRP-1 plays many important functions, including angiogenesis, neuronal development, and the regulation of immune responses. Additionally, the presence of this glycoprotein on the host cell membrane significantly augments the infection and spread of SARS-CoV-2. Literature data suggest that NRP-1 facilitates entry of the virus into the central nervous system through the olfactory epithelium of the nasal cavity. Moreover, published findings show that interfering with VEGF-A\/NRP-1 using NRP-1 inhibitors may produce an analgesic effect. The review describes an association between NRP-1, SARS-CoV-2 and, inter alia, pathological changes in the retina. Based on the published findings, we suggest that NRP-1 is a very important mediator implicated in, inter alia, neurological manifestations of SARS-CoV-2 infection. Additionally, it appears that the use of NRP-1 inhibitors is a promising therapeutic strategy for the treatment of SARS-CoV-2 infection.<\/jats:p>","DOI":"10.3390\/jcm10132772","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T11:01:38Z","timestamp":1624532498000},"page":"2772","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4854-7155","authenticated-orcid":false,"given":"Monika","family":"Gudowska-Sawczuk","sequence":"first","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4075-8479","authenticated-orcid":false,"given":"Barbara","family":"Mroczko","sequence":"additional","affiliation":[{"name":"Department of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland"},{"name":"Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Waszyngtona 15A St., 15-269 Bialystok, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1097\/01.inf.0000188166.17324.60","article-title":"History and Recent Advances in Coronavirus Discovery","volume":"24","author":"Kahn","year":"2005","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1128\/MMBR.69.4.635-664.2005","article-title":"Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus","volume":"69","author":"Weiss","year":"2005","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Yang, Y., Peng, F., Wang, R., Guan, K., Jiang, T., Xu, G., Sun, J., and Chang, C. (2020). The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J. Autoimmun., 109.","DOI":"10.1016\/j.jaut.2020.102434"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kirtipal, N., Bharadwaj, S., and Kang, S.G. (2020). From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses. Infect. Genet. Evol., 85.","DOI":"10.1016\/j.meegid.2020.104502"},{"key":"ref_5","unstructured":"World Health Organisation (WHO) (2021). Weekly Epidemiological Update on COVID-19, WHO."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wang, M.-Y., Zhao, R., Gao, L.-J., Gao, X.-F., Wang, D.-P., and Cao, J.-M. (2020). SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.587269"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Naqvi, A.A.T., Fatima, K., Mohammad, T., Fatima, U., Singh, I.K., Singh, A., Atif, S.M., Hariprasad, G., Hasan, G.M., and Hassan, I. (2020). Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim. Biophys. Acta BBA Mol. Basis Dis., 1866.","DOI":"10.1016\/j.bbadis.2020.165878"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Romano, M., Ruggiero, A., Squeglia, F., Maga, G., and Berisio, R. (2020). A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. Cells, 9.","DOI":"10.20944\/preprints202004.0510.v1"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Li, X., Chang, J., Chen, S., Wang, L., Yau, T.O., Zhao, Q., Hong, Z., Ruan, J., Duan, G., and Gao, S. (2021). Genomic Feature Analysis of Betacoronavirus Provides Insights into SARS and COVID-19 Pandemics. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.614494"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ribero, M.S., Jouvenet, N., Dreux, M., and Nisole, S. (2020). Interplay between SARS-CoV-2 and the type I interferon response. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008737"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Mihaescu, G., Chifiriuc, M.C., Iliescu, C., Vrancianu, C.O., Ditu, L.-M., Marutescu, L.G., Grigore, R., Berte\u015eteanu, \u015e., Constantin, M., and Pircalabioru, G.G. (2020). SARS-CoV-2: From Structure to Pathology, Host Immune Response and Therapeutic Management. Microorganisms, 8.","DOI":"10.3390\/microorganisms8101468"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Post, N., Eddy, D., Huntley, C., van Schalkwyk, M.C.I., Shrotri, M., Leeman, D., Rigby, S., Williams, S.V., Bermingham, W.H., and Kellam, P. (2020). Antibody response to SARS-CoV-2 infection in humans: A systematic review. PLoS ONE, 15.","DOI":"10.1101\/2020.08.25.20178806"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.abf0732","article-title":"Enhancing host cell infection by SARS-CoV-2","volume":"370","author":"Kielian","year":"2020","journal-title":"Science"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41392-020-00460-9","article-title":"Not only ACE2\u2014the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19","volume":"6","author":"Kyrou","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Katopodis, P., Kerslake, R., Davies, J., Randeva, H.S., Chatha, K., Hall, M., Spandidos, D.A., Anikin, V., Polychronis, A., and Robertus, J.L. (2021). COVID-19 and SARS-CoV-2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease. Int. J. Mol. Med., 47.","DOI":"10.3892\/ijmm.2021.4897"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.molimm.2017.08.010","article-title":"Role of neuropilin-2 in the immune system","volume":"90","author":"Schellenburg","year":"2017","journal-title":"Mol. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2613.2012.00810.x","article-title":"Neuropilins: Expression and roles in the epithelium","volume":"93","author":"Wild","year":"2012","journal-title":"Int. J. Exp. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Daly, J.L., Simonetti, B., Klein, K., Chen, K.-E., Williamson, M.K., Ant\u00f3n-Pl\u00e1garo, C., Shoemark, D.K., Sim\u00f3n-Gracia, L., Bauer, M., and Hollandi, R. (2020). Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science.","DOI":"10.1101\/2020.06.05.134114"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Alnomasy, S.F. (2021). Virus-receptor interactions of SARS-CoV-2 spike receptor-binding domain and human neuropilin-1 b1 domain. Saudi J. Biol. Sci.","DOI":"10.1016\/j.sjbs.2021.03.074"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Li, Z., and Buck, M. (2021). Neuropilin-1 Assists SARS-CoV-2 Infection by Stimulating the Separation of Spike Protein Domains S1 and S2. BiorXiv, 0106.","DOI":"10.1101\/2021.01.06.425627"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Moin, A.S.M., Sathyapalan, T., Atkin, S.L., and Butler, A.E. (2021). The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome. Metab. Open, 9.","DOI":"10.1016\/j.metop.2021.100079"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Ojha","year":"2020","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Berlit, P., B\u00f6sel, J., Gahn, G., Isenmann, S., Meuth, S.G., Nolte, C.H., Pawlitzki, M., Rosenow, F., Schoser, B., and Thomalla, G. (2020). \u201cNeurological manifestations of COVID-19\u201d\u2014Guideline of the German society of neurology. Neurol. Res. Prac., 2.","DOI":"10.1186\/s42466-020-00097-7"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., and Wang, D. (2020). Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol., 77.","DOI":"10.1001\/jamaneurol.2020.1127"},{"key":"ref_28","first-page":"4221","article-title":"Neuropilin-1 as a new potential SARS-CoV-2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID-19","volume":"22","author":"Davies","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Heinonen, S., Helve, O., Andersson, S., Jan\u00e9r, C., S\u00fcvari, L., and Kaskinen, A. (2021). Nasal expression of SARS-CoV-2 entry receptors in newborns. Arch. Dis. Child. Fetal Neonatal Ed., 2020.","DOI":"10.1136\/archdischild-2020-321334"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/eji.200324799","article-title":"Frontline: Neuropilin-1: A surface marker of regulatory T cells","volume":"34","author":"Bruder","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"De Vlaeminck, Y., Bonelli, S., Awad, R.M., Dewilde, M., Rizzolio, S., Lecocq, Q., Bolli, E., Santos, A.R., Laoui, D., and Schoonooghe, S. (2020). Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development. Cancers, 12.","DOI":"10.3390\/cancers12123582"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mone, P., Gambardella, J., Wang, X., Jankauskas, S.S., Matarese, A., and Santulli, G. (2021). miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: In-sights for COVID-19 neurological manifestations. Res. Sq.","DOI":"10.21203\/rs.3.rs-192099\/v1"},{"key":"ref_33","unstructured":"Purves, D., Augustine, G., Fitzpatrick, D., Katz, L., LaMantia, A., McNamara, J., and Williams, S. (2020, May 20). Neuroscience, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK10965\/."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/j.pain.0000000000002097","article-title":"SARS-CoV-2 Spike protein co-opts VEGF-A\/Neuropilin-1 receptor signaling to in-duce analgesia","volume":"162","author":"Moutal","year":"2021","journal-title":"Pain"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1074\/jbc.M111.331140","article-title":"Structural Basis for Selective Vascular Endothelial Growth Factor-A (VEGF-A) Binding to Neuropilin-1","volume":"287","author":"Parker","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Perez-Miller, S., Patek, M., Moutal, A., Cabel, C.R., Thorne, C.A., Campos, S.K., and Khanna, R. (2020). In silico identification and validation of inhibitors of the interaction be-tween neuropilin receptor 1 and SARS-CoV-2 Spike protein. BioRxiv.","DOI":"10.1101\/2020.09.22.308783"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Hopkins, C., Lechien, J.R., and Saussez, S. (2021). More that ACE2? NRP1 may play a central role in the underlying pathophysiological mechanism of olfactory dysfunction in COVID-19 and its association with enhanced survival. Med. Hypotheses, 146.","DOI":"10.1016\/j.mehy.2020.110406"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/acschemneuro.0c00619","article-title":"Novel Compounds Targeting Neuropilin Receptor 1 with Potential to Interfere with SARS-CoV-2 Virus Entry","volume":"12","author":"Patek","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Parker, M., Xu, P., Guo, H.-F., and Kooi, C.W.V. (2012). Mechanism of Selective VEGF-A Binding by Neuropilin-1 Reveals a Basis for Specific Ligand Inhibition. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049177"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Vique-S\u00e1nchez, J.L. (2021). Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking. Bioorganic Med. Chem., 33.","DOI":"10.1016\/j.bmc.2021.116040"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"20109","DOI":"10.1073\/pnas.1921315117","article-title":"Necroptosis-based CRISPR knockout screen reveals Neuropilin-1 as a critical host factor for early stages of murine cytomegalovirus infection","volume":"117","author":"Lane","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.cell.2018.06.028","article-title":"An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor","volume":"174","author":"Marcandalli","year":"2018","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-020-00185-x","article-title":"\u201cThe ancient and the new\u201d: Is there an interaction between cytomegalovirus and SARS-CoV-2 infection?","volume":"17","author":"Moss","year":"2020","journal-title":"Immun. Ageing"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Furman, D., Jojic, V., Sharma, S., Shen-Orr, S.S., Angel, C.L., Onengut-Gumuscu, S., Kidd, B., Maecker, H.T., Concannon, P., and Dekker, C.L. (2015). Cytomegalovirus infection enhances the immune response to influenza. Sci. Transl. Med., 7.","DOI":"10.1126\/scitranslmed.aaa2293"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.isci.2018.12.005","article-title":"Neuropilin-1 Controls Endothelial Homeostasis by Regulating Mitochondrial Function and Iron-Dependent Oxidative Stress","volume":"11","author":"Issitt","year":"2019","journal-title":"Iscience"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Barakat, B., and Almeida, M.E.F. (2021). Biochemical and immunological changes in obesity. Arch. Biochem. Biophys., 708.","DOI":"10.1016\/j.abb.2021.108951"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Marinho, P.M., Marcos, A.A., Romano, A.C., Nascimento, H., and Belfort, R. (2020). Retinal findings in patients with COVID-19. Lancet, 395.","DOI":"10.1016\/S0140-6736(20)31014-X"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1007\/s13577-021-00532-0","article-title":"Neuropilin-1 may be responsible for retinal findings in patients with COVID-19","volume":"34","author":"Abdalla","year":"2021","journal-title":"Hum. Cell"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Zhao, G., Weiner, A.I., Neupauer, K.M., Costa, M.F.D.M., Palashikar, G., Adams-Tzivelekidis, S., Mangalmurti, N.S., and Vaughan, A.E. (2020). Regeneration of the pulmonary vascular endothelium after viral pneumonia requires COUP-TF2. Sci. Adv., 6.","DOI":"10.1126\/sciadv.abc4493"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/13\/2772\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:22:57Z","timestamp":1760163777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/13\/2772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,24]]},"references-count":49,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["jcm10132772"],"URL":"https:\/\/doi.org\/10.3390\/jcm10132772","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,24]]}}}